| Controlled Substance Ordering System (CSOS) |
Description
HDMA has worked with the U.S. Drug Enforcement Administration (DEA)
on an electronic commerce initiative to facilitate the electronic ordering
of Schedule II Controlled Substances, commonly referred to as “CSOS.”
This important partnership involved dialogue and collaboration, as well as
connecting the regulatory/business process necessities with the technical aspects
of setting up an electronic ordering system for Schedule II controlled substances.
HDMA and DEA began a series of discussions in 1999 that have evolved into the
current initiative. The overall goal was to simplify the ordering of Schedule
II controlled substances while retaining the underlying "closed distribution
system" principles
of the DEA Order Form (Form 222). This new process allows the automation
of a number of other steps, such as verification, audits, and reporting.
General Information
Committees/Task Forces
Contact
John Howells
Senior Director, Industry Relations
703-885-0277
jhowells@hdmanet.org
Anita Ducca
Senior Director, Regulatory Affairs & Healthcare Policy
703-885-0240
aducca@hdmanet.org
|
| |
|
